Israeli study finds 94% drop in cases with Pfizer vaccine

 

JERUSALEM (Reuters) - Israel’s largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer’s vaccine in the country’s biggest study to date.

“It shows unequivocally that Pfizer’s coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study,” said Ran Balicer, Clalit’s chief innovation officer….

 https://www.reuters.com/article/reutersComService_2_MOLT/idUSKBN2AE0Q2